GLP-3 RTA vs KLOW
GLP-3 RTA and KLOW come from different research areas and are studied in largely separate models — researchers usually compare them when scoping a broader protocol.
✓ both US-made · third-party tested · batch COA on every order
at a glance
what each one is
GLP-3 RTA
Synthetic triple-agonist peptide
GLP-3 RTA is a synthetic single-chain peptide engineered to act at three related class B G-protein-coupled receptors at once: the GLP-1 receptor, the GIP receptor, and the glucagon receptor. Its backbone is derived from the incretin peptide family and carries a fatty-acid modification that extends plasma half-life in pre-clinical systems, making it a widely cited reference agonist in incretin-receptor research.
full GLP-3 RTA profile →KLOW
Four-peptide research blend · cellular research
KLOW is a research blend that combines four of the most-studied peptides (BPC-157, TB-500, GHK-Cu, and KPV) in a single vial. Verve supplies it as a high-purity, batch-tested research preparation for cellular research.
full KLOW profile →where the research differs
Both compounds are supplied strictly for laboratory research use only. Reported research contexts for each:
GLP-3 RTA
- GLP-1, GIP, and glucagon receptor agonism research
- cAMP and class B GPCR signaling research models
- Comparative single-, dual-, and triple-agonist pharmacology studies
- Metabolic-pathway and nutrient-handling research models
- Peptide half-life, lipidation, and stability research
KLOW
- Multi-compound cellular research
- Tissue-repair research models
- Extracellular-matrix and remodeling research
- Comparative peptide research
shop either compound
Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.
build a stack with both →frequently asked
What is GLP-3 RTA?
GLP-3 RTA is a synthetic peptide that acts as an agonist at three receptors — GLP-1, GIP, and glucagon. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is GLP-3 RTA studied for in research?
In in-vitro and pre-clinical models it is used as a reference agonist in incretin-receptor pharmacology, cAMP signaling, and metabolic-pathway research. Verve makes no claims about use in humans or animals.
What is KLOW?
KLOW is a research blend of four peptides (BPC-157, TB-500, GHK-Cu, and KPV) in one vial. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is KLOW studied for in research?
It is used in multi-compound cellular and tissue-repair research models where these four peptides are studied together. Verve makes no health claims.
related comparisons
verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.